Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Event Details


Charles River Laboratories International, Inc. at the Jefferies London Healthcare Conference Presentation
Thursday, November 16, 2017 5:40 a.m. ET  
Webcast Presentation
Click here for webcast
Supporting Materials
Download Event Supporting MaterialJefferies London Healthcare Conference Presentation

Stock Quote

CRL (common)
Price
$104.88
Change (%)
- 1.12 (1.06%)
Volume
300,979
Exchange
NYSE
Data as of 12/14/17 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)